| Peer-Reviewed

Male Sexual Disorders of Patients with Cancer in Medical Oncology Service in University Hospital of Brazzaville

Received: 8 July 2021    Accepted: 16 July 2021    Published: 23 July 2021
Views:       Downloads:
Abstract

Considered as taboo, sexual difficulties and couple intimacy remain rarely tackled by patients and again less by the oncologist practicians. It might seem that faced with the vital stake of disease, this kind of worries seem to be frivolous, indeed shameful to be tackled. The current study had an objective to assess the impacts of cancer on male sexuality followed and treated in medical service in University Hospital of Brazzaville. Studying male sexual disorder of patients with cancer in medical oncology service in university hospital of Brazzaville. It was a retrospective study, from April 1st to July 31st 2018. All patients with cancer aged at least 18 years old with a performance of WHO between 0-2 were included. About one hundred (100) patients we examined whose eighty four (84) men, it appears that the most sexual disorder found is the one of craving, then the one of orgasm. Certain troubles had a link with the onset of cancer (p<5). The men presented a great number of sexual disorder had a cancer of digestive type (47.6%), urogenital (22.6%) and soft tissue (19%). In terms of received treatments: surgery-chemotherapy (men 22%), chemotherapy only (21.4%), surgery only (19%). The global frequency of sexual disorders to all patients is 98.4% in medical oncology service. It is important to consider those sexual disorders at the time of the care of those patients according to their repercussion on life quality during and after all treatment even in the absence of all progressive nature of disease. The most sexual disorder found is the one of craving.

Published in International Journal of Clinical Oncology and Cancer Research (Volume 6, Issue 3)
DOI 10.11648/j.ijcocr.20210603.13
Page(s) 118-124
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Sexual Disorders, Cancer, Craving, Orgasm, Frequency

References
[1] Bondil P, Habold D. Cancer et sexualité: les médecins ne doivent plus faire l’impasse. La lettre du cancérologue 2012 Mar; 21 (3): 165-70.
[2] Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mather C, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. J Cancer 2015; 136 (5): 359-86.
[3] Bouhnik AD, Courbiere B, Courtois E, Mancini J, Preau M. Sexualité, vie affective et conjugale. La vie cinq ans après un diagnostic de cancer. Institut National du Cancer 2018: 326–39.
[4] A. Katz, Don S Dizon. Sexuality after cancer: A Model for Male Survivors. J Sex Med. 2016; 13 (1): 70-8.
[5] Patrice Lopès et François-Xavier Poudat. Sexualité au masculin. Manuel de sexologie. Elseiver Paris Masson 2ème édition, 2014; 97-127.
[6] Lemaire A, Alexandre B. Evolution de la personne porteuse d’une pathologie chronique et conséquences sur la sexualité. J sexologies 2006; 15: 108─15.
[7] Schover LR et al. Sexual dysfunction and infertility as late effects of cancer treatment. EJC Suppl 2014; 12 (1): 41─53.
[8] Sadovsky R, Basson R, Krychman M, Morales AM, Schover L, Wang R, et al. Cancer and sexual problems. J Sex Med 2010; 7: 349–73.
[9] Valdivieso M, Kujawa AM, Jones T, al. Cancer Survivors in the United States: A Review of the Literature and a Call to Action. Int J Med Sci 2012; 9 (2): 163–173.
[10] Hautamaki Lammien K, Lipiäinen L, Beaver K, Lehto J et al. Identifying cancer patients with greater need for information about sexual issues. European journal of oncology nursing 2013. 17 (1): 9-5.
[11] Errihani M, Elghissassi I, Mellas N, Belbaraka R, Messmoudi M, Kaikani W. Impact of cancer on sexuality, how is the moroccan patient affected? Sexologies 2009.19 (4): 92─98.
[12] Habold D, Bondil P. Cancers de l’homme et retour à la sexualité. La Lettre du Cancérologue 2010; 29: 170-9.
[13] Park ER, Norris RL, Bober SL. Sexual health communication during cancer care: barriers and recommendations. Cancer J 2009; 15: 74-7.
[14] Pachman DR, Barton DL, Swetz KM et al. Troublesome Symptoms in Cancer Survivors: Fatigue, Insomnia, Neuropathy, and Pain. J Clin Oncol 2012; 30 (30): 3687─96.
[15] Carlsen K, Dalton SO, Frederiksen K, Diderichsen F, Johansen C. Are cancer survivors at an increased risk for divorce? A Danish cohort study. Eur j cancer oxf Engl. 2007; 43 (14) 2093-9.
[16] Hall AE, Boyes AW, Bowman J, Walsh RA, James EL, Girgis A. Young adult cancer survivors’ psychosocial well-being: a cross-sectional study assessing quality of life, unmet needs, and health behaviors. Support Care Cancer 2012; 20: 1333–41.
[17] Reese JB, Shelby RA, Abernethy AP. Sexual concerns in lung cancer patients: an examination of predictors and moderating effects of age and gender. Support Care Cancer 2011; 19: 161–5.
[18] Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fossa˚ SD. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int 2012; 109: 1366–74.
[19] Milbury K, Cohen L, Jenkins R, Skibber JM, Schover LR. The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for colorectal cancer. Support Care Cancer 2013; 21: 793–802.
[20] Bober SL, Sanchez Varela V. sexuality in adult cancer survivors: challenges and intervention. J clin oncol. 2012; 30: 3712-9.
[21] Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008. 358: 1250-1261.
[22] Potosky AL, Davis WW, Hoffman RM, et al: Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst. 2004. 96: 1358-1367.
[23] van der Wielen GJ, van Putten WL, Incrocci L: Sexual function after three-dimensional conformal radiotherapy for prostate cancer: Results from a dose-escalation trial. Int J Radiat Oncol Biol Phys. 2007. 68: 479-484.
[24] Elliott S, Latini DM, Walker LM, et al: Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life. J Sex Med. 2010. 7: 2996-3010.
[25] Lilleby W, Stensvold A, Dahl AA. Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: a study of adverse effects and their relation to quality of life. Prostate 2013; 73: 1038–47.
[26] Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013; 368: 436–45.
[27] Nelson C, Scardino PT, Eastham JA, Mulhall JP. Back to baseline: erectile function recovery after radical prostatectomy from the patients’ perspective. J Sex Med 2013; 6: 1636–43.
[28] Den Oudsten BL, Traa MJ, Thong MS, Martijn H, De Hingh IH, Bosscha K, et al. Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: a population-based study. Eur J Cancer 2012; 48: 3161–70.
[29] Kyrdalen AE, Dahl AA, Hernes E, Sma˚stuen MC, Fossa˚ SD. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer. BJU Int 2013; 111: 221–32.
[30] Lindau ST, Surawska H, Paice J, Baron SR. Communication about sexuality and intimacy in couples affected by lung cancer and their clinical-care providers. Psychooncology 2011; 20: 179–85.
[31] Thygesen KH, Schjødt I, Jarden M. The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant 2012; 47: 716–24.
[32] Henry M, Habib LA, Morrison M, Yang JW, Li XJ, Lin S et al. Head and neck cancer patients want us to support them psychologically in the posttreatment period: Survey results. Palliat Support Care 2013, 24.
[33] Strasser F, Palmer JL, Schover LR, Yusuf SW, Pisters K, Vassilopoulou-Sellin R, et al. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer 2006; 107: 2949–57.
[34] Frey AU, Sønksen J, Fode M. Neglected side effects after radical prostatectomy: a systematic review. J Sex Med 2014. 11 (2): 374-85.
[35] Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, SPCG-4 Investigators, et al. Long-term quality of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol 2011; 12: 891–9.
[36] Taylor KL, Luta G, Miller AB, Church TR, Kelly SP, Muenz LR, et al. Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol 2012; 30: 2768–75.
[37] Bentzen AG, Balteskard L, Wandera˚ s EH, Frykholm G, Wilsgaard T, Dahl O, et al. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncol 2013; 52: 736–44.
[38] Kiserud CE, Schover LR, Dahl AA, Fossa˚ A, Bjøro T, Loge JH, et al. Do male lymphoma survivors have impaired sexual function? J Clin Oncol 2009; 27: 6019–26.
[39] K K Manier, L S Rowe, J Welsh and Terre B Armstrong. The Impact and incidence of altered body image in patients with head and neck tumors: a systematic review. Neurooncol Pract. 2018; 5 (4): 203-213.
[40] T. Almont, A- Deborah Bouhnik, Ali Ben Charif, Marc- Karim Bendiane, C Couteau, C Manceau, J Mancini E Huyghe. Sexual Health Problems and Discussion in Colorectal Cancer Patients Two Years after Diagnosis: a national Cross-Sectional Study. J Sex Med. 2019; 16 (1): 96- 10.
[41] Herman JM, Narang AK, Griffith KA, Zalupski MM, Reese JB, Gearhart SL, et al. The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2013; 85: e15–19.
[42] Willemse PM, Burggraaf J, Hamdy NA, Weijl NI, Vossen CY, van Wulften L, et al. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors. Br J Cancer 2013; 109: 60–7.
[43] Recklitis CJ. Sanchez Varela V, Ng A, Mauch P, Bober S. Sexual functioning in long-term survivors of Hodgkin’s lymphoma. Psychooncology 2010; 19: 1229–33.
Cite This Article
  • APA Style

    Judith Nsondé Malanda, Roland Banga-Mouss, Chellet Bilquis Bambi, Aubierge Victoire Kimpamboudi Matondo, Inès Frédérique Nsondé Mondzié, et al. (2021). Male Sexual Disorders of Patients with Cancer in Medical Oncology Service in University Hospital of Brazzaville. International Journal of Clinical Oncology and Cancer Research, 6(3), 118-124. https://doi.org/10.11648/j.ijcocr.20210603.13

    Copy | Download

    ACS Style

    Judith Nsondé Malanda; Roland Banga-Mouss; Chellet Bilquis Bambi; Aubierge Victoire Kimpamboudi Matondo; Inès Frédérique Nsondé Mondzié, et al. Male Sexual Disorders of Patients with Cancer in Medical Oncology Service in University Hospital of Brazzaville. Int. J. Clin. Oncol. Cancer Res. 2021, 6(3), 118-124. doi: 10.11648/j.ijcocr.20210603.13

    Copy | Download

    AMA Style

    Judith Nsondé Malanda, Roland Banga-Mouss, Chellet Bilquis Bambi, Aubierge Victoire Kimpamboudi Matondo, Inès Frédérique Nsondé Mondzié, et al. Male Sexual Disorders of Patients with Cancer in Medical Oncology Service in University Hospital of Brazzaville. Int J Clin Oncol Cancer Res. 2021;6(3):118-124. doi: 10.11648/j.ijcocr.20210603.13

    Copy | Download

  • @article{10.11648/j.ijcocr.20210603.13,
      author = {Judith Nsondé Malanda and Roland Banga-Mouss and Chellet Bilquis Bambi and Aubierge Victoire Kimpamboudi Matondo and Inès Frédérique Nsondé Mondzié and Bab Salam Ngouaka and Siméon Stéphane Moubié},
      title = {Male Sexual Disorders of Patients with Cancer in Medical Oncology Service in University Hospital of Brazzaville},
      journal = {International Journal of Clinical Oncology and Cancer Research},
      volume = {6},
      number = {3},
      pages = {118-124},
      doi = {10.11648/j.ijcocr.20210603.13},
      url = {https://doi.org/10.11648/j.ijcocr.20210603.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20210603.13},
      abstract = {Considered as taboo, sexual difficulties and couple intimacy remain rarely tackled by patients and again less by the oncologist practicians. It might seem that faced with the vital stake of disease, this kind of worries seem to be frivolous, indeed shameful to be tackled. The current study had an objective to assess the impacts of cancer on male sexuality followed and treated in medical service in University Hospital of Brazzaville. Studying male sexual disorder of patients with cancer in medical oncology service in university hospital of Brazzaville. It was a retrospective study, from April 1st to July 31st 2018. All patients with cancer aged at least 18 years old with a performance of WHO between 0-2 were included. About one hundred (100) patients we examined whose eighty four (84) men, it appears that the most sexual disorder found is the one of craving, then the one of orgasm. Certain troubles had a link with the onset of cancer (p<5). The men presented a great number of sexual disorder had a cancer of digestive type (47.6%), urogenital (22.6%) and soft tissue (19%). In terms of received treatments: surgery-chemotherapy (men 22%), chemotherapy only (21.4%), surgery only (19%). The global frequency of sexual disorders to all patients is 98.4% in medical oncology service. It is important to consider those sexual disorders at the time of the care of those patients according to their repercussion on life quality during and after all treatment even in the absence of all progressive nature of disease. The most sexual disorder found is the one of craving.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Male Sexual Disorders of Patients with Cancer in Medical Oncology Service in University Hospital of Brazzaville
    AU  - Judith Nsondé Malanda
    AU  - Roland Banga-Mouss
    AU  - Chellet Bilquis Bambi
    AU  - Aubierge Victoire Kimpamboudi Matondo
    AU  - Inès Frédérique Nsondé Mondzié
    AU  - Bab Salam Ngouaka
    AU  - Siméon Stéphane Moubié
    Y1  - 2021/07/23
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ijcocr.20210603.13
    DO  - 10.11648/j.ijcocr.20210603.13
    T2  - International Journal of Clinical Oncology and Cancer Research
    JF  - International Journal of Clinical Oncology and Cancer Research
    JO  - International Journal of Clinical Oncology and Cancer Research
    SP  - 118
    EP  - 124
    PB  - Science Publishing Group
    SN  - 2578-9511
    UR  - https://doi.org/10.11648/j.ijcocr.20210603.13
    AB  - Considered as taboo, sexual difficulties and couple intimacy remain rarely tackled by patients and again less by the oncologist practicians. It might seem that faced with the vital stake of disease, this kind of worries seem to be frivolous, indeed shameful to be tackled. The current study had an objective to assess the impacts of cancer on male sexuality followed and treated in medical service in University Hospital of Brazzaville. Studying male sexual disorder of patients with cancer in medical oncology service in university hospital of Brazzaville. It was a retrospective study, from April 1st to July 31st 2018. All patients with cancer aged at least 18 years old with a performance of WHO between 0-2 were included. About one hundred (100) patients we examined whose eighty four (84) men, it appears that the most sexual disorder found is the one of craving, then the one of orgasm. Certain troubles had a link with the onset of cancer (p<5). The men presented a great number of sexual disorder had a cancer of digestive type (47.6%), urogenital (22.6%) and soft tissue (19%). In terms of received treatments: surgery-chemotherapy (men 22%), chemotherapy only (21.4%), surgery only (19%). The global frequency of sexual disorders to all patients is 98.4% in medical oncology service. It is important to consider those sexual disorders at the time of the care of those patients according to their repercussion on life quality during and after all treatment even in the absence of all progressive nature of disease. The most sexual disorder found is the one of craving.
    VL  - 6
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Carcinology Service University Hospital in Brazzaville, Brazzaville, Congo

  • Urology Service and Andrology Service University Hospital in Brazzaville, Brazzaville, Congo

  • Carcinology Service University Hospital in Brazzaville, Brazzaville, Congo

  • Surgery Service Makelekele Hospital Brazzaville, Brazzaville, Congo

  • Carcinology Service University Hospital in Brazzaville, Brazzaville, Congo

  • Medicine Service Makelekele Hospital Brazzaville, Brazzaville, Congo

  • Carcinology Service Military Central Hospital P. M Brazzaville, Brazzaville, Congo

  • Sections